HEM Pharma is in talks with Amway for an additional supply contract according to Hanyang Securities. The company is constructing a new factory in Sejong City to address supply shortages, but even with this, shortages are expected due to the ongoing discussions with Amway. HEM Pharma’s products, including ‘MyLab’, a microbiome testing service, and probiotics ‘MyLab Solution’ and ‘Phytobiome Product Line’, are exclusively sold by Amway and are experiencing high demand, leading to stockouts.
Original Article: Read More
Auto-posted at: 2025-03-31 09:01:09